Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22552L |
AD57
|
Bcr-Abl; Src | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
AD57是c-Src 和Abl 的有效抑制剂,IC50分别为0.025μM 和0.041μM。 | |||
T22552 |
AD57 (hydrochloride)
|
Others | Others |
AD57, as polypharmacological cancer therapeutic, is designed to regulate multiple targets related to cancer blocks the receptor tyrosine kinase RET in Drosophila (IC50: 2 nM). AD57 effectively suppresses tyrosine kinase RET, weakens the activity of numero |